Parimer attended the 2025 BIO International Convention with SCbio, joining thousands of innovators, scientists, startups, and partners from across the globe. There were no flashy product launches or seismic announcements and that’s exactly why it was valuable. What stood out most wasn’t on the main stage. It was in the side conversations, the coffee line catchups, and the breakout panels that hinted at what’s really shaping the future of biotech, especially for early-stage t

Parimer partners with universities, research teams, and tech transfer offices to bridge the gap between early-stage discovery and development. By offering flexible, responsive support across the product development lifecycle, Parimer enables academic innovations to move from lab bench to real-world application. 

America’s manufacturing industry has always been a backbone of innovation and progress  building, solving, and producing with grit and precision. Today, with rising labor costs abroad, new tariffs, and growing interest in U.S.-based production, attention is once again turning toward the people who make things here at home. This renewed focus isn’t just economic, it’s personal. At Parimer, we take pride in being part of this resurgence and doing our part to strengthen American

The global trade landscape shifted again recently, when the U.S. government imposed another wave of steep tariffs on Chinese imports. Businesses across the country braced for the ripple effects: cost increases, production delays, and major disruptions across supply chains. For many, this news is triggering a mad scramble to reevaluate vendors and pricing structures.  For Parimer and our customers, it is business as usual. One of the reasons for this is because Parimer does

Parimer offers a flexible, client-centric CDMO designed for companies that need agility, innovation, and tailored solutions.

How Parimer and The Michael J. Fox Foundation are Making a Difference

Bringing a drug to market can seem daunting, often with unique hurdles, particularly for small and mid-sized companies. These challenges usu

Equipped with state-of-the-art research and customer-centric intellectual property strategies, Parimer helps its partners create groundbreak

New drugs in the United States are a slow, complicated, and costly process. They usually begin in university research labs and can take deca

Background Iterro has developed a proprietary and novel manufacturing process to produce some of the world's finest shrimp using a...